ClinicalTrials.govpublic full text
Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment
pd-1 antibodies, exercise, melanoma, cancer, feasibility, checkpoint inhibitors, immune system, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830950
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.